Doris H. Schmidt
Sigmund Freud Str. 25
Bonn, NW 53127, Germany
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.
Journal: Cancer research
Published: May 10, 2023
Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression.
Journal: Scientific reports
Published: February 21, 2023
Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.
Journal: American journal of translational research
Published: September 25, 2022
Systematic expression analysis of m6A RNA methyltransferases in clear cell renal cell carcinoma.
Journal: BJUI compass
Published: January 06, 2021
N6 -Methyladenosine (m6 A) readers are dysregulated in renal cell carcinoma.
Journal: Molecular carcinogenesis
Published: October 18, 2020
Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma.
Journal: Translational oncology
Published: June 04, 2020
Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma.
Journal: Anticancer research
Published: April 05, 2020
Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
Journal: European urology focus
Published: March 18, 2020
The contrasting roles of Dysferlin during tumor progression in renal cell carcinoma.
Journal: Urologic oncology
Published: March 01, 2020
Last Updated: 09/26/2026